APO Research
Talk to an analyst

APO RESEARCH · REPORT

Laboratory Molecular Cloning Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Laboratory Molecular Cloning Solutions Market Outlook and Growth Opportunities 2026

2 May 2026192 pages

Choose your research edition.

Industry ResearchLaboratory Molecular Cloning Solutions Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Laboratory Molecular Cloning Solutions Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Laboratory Molecular Cloning Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Laboratory Molecular Cloning Solutions Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Laboratory Molecular Cloning Solutions Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Laboratory Molecular Cloning Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Laboratory Molecular Cloning Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Laboratory Molecular Cloning Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Laboratory Molecular Cloning Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Laboratory Molecular Cloning Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Laboratory Molecular Cloning Solutions market include VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene and Prospec-Tany Technogene, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Laboratory Molecular Cloning Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Laboratory Molecular Cloning Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Laboratory Molecular Cloning Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Laboratory Molecular Cloning Solutions market.

Laboratory Molecular Cloning Solutions Segment by Company

VectorBuilder

BioServUK

GenScript

urofins Genomics

Innoprot

Genewiz

Bio-Fab Research

OriGene

Prospec-Tany Technogene

Addgene

Protein Ark

Protomnis

RD-Biotech

Charles River

Shandong Vigene Biosciences

Nanjingjinsirui Science & Technology Biology Corp.

Tiangen Biotech (Beijing) Co., Ltd.

Laboratory Molecular Cloning Solutions Segment by Type

Viral Vector

Non-viral Vectors

Laboratory Molecular Cloning Solutions Segment by Application

Laboratory

Research Institute

Others

Laboratory Molecular Cloning Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Laboratory Molecular Cloning Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Laboratory Molecular Cloning Solutions key companies, revenue, market share, and recent developments.

3. To split the Laboratory Molecular Cloning Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Laboratory Molecular Cloning Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Laboratory Molecular Cloning Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Laboratory Molecular Cloning Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory Molecular Cloning Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laboratory Molecular Cloning Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory Molecular Cloning Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laboratory Molecular Cloning Solutions industry.

Chapter 3: Detailed analysis of Laboratory Molecular Cloning Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Laboratory Molecular Cloning Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Laboratory Molecular Cloning Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Laboratory Molecular Cloning Solutions Industry Trends Table 2. Laboratory Molecular Cloning Solutions Industry Drivers Table 3. Laboratory Molecular Cloning Solutions Industry Opportunities and Challenges Table 4. Laboratory Molecular Cloning Solutions Industry Restraints Table 5. Global Laboratory Molecular Cloning Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Laboratory Molecular Cloning Solutions Revenue Share by Company (2021-2026) Table 7. Global Laboratory Molecular Cloning Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Laboratory Molecular Cloning Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Laboratory Molecular Cloning Solutions Company, Product Type & Application Table 10. Global Laboratory Molecular Cloning Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Laboratory Molecular Cloning Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Viral Vector Table 15. Significant Companies of Non-viral Vectors Table 16. Global Laboratory Molecular Cloning Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Laboratory Molecular Cloning Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Laboratory Molecular Cloning Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Laboratory Molecular Cloning Solutions Sales Value Share by Type (2021-2026) Table 20. Global Laboratory Molecular Cloning Solutions Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Laboratory Table 22. Significant Companies of Research Institute Table 23. Significant Companies of Others Table 24. Global Laboratory Molecular Cloning Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Laboratory Molecular Cloning Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Laboratory Molecular Cloning Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Laboratory Molecular Cloning Solutions Sales Value Share by Application (2021-2026) Table 28. Global Laboratory Molecular Cloning Solutions Sales Value Share by Application (2027-2032) Table 29. Global Laboratory Molecular Cloning Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Laboratory Molecular Cloning Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Laboratory Molecular Cloning Solutions Sales Value Share by Region (2021-2026) Table 32. Global Laboratory Molecular Cloning Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Laboratory Molecular Cloning Solutions Sales Value Share by Region (2027-2032) Table 34. Global Laboratory Molecular Cloning Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Laboratory Molecular Cloning Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Laboratory Molecular Cloning Solutions Sales Value Market Share by Country (2021-2026) Table 37. Global Laboratory Molecular Cloning Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Laboratory Molecular Cloning Solutions Sales Value Market Share by Country (2027-2032) Table 39. VectorBuilder Company Information Table 40. VectorBuilder Business Overview Table 41. VectorBuilder Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. VectorBuilder Laboratory Molecular Cloning Solutions Product Portfolio Table 43. VectorBuilder Recent Development Table 44. BioServUK Company Information Table 45. BioServUK Business Overview Table 46. BioServUK Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. BioServUK Laboratory Molecular Cloning Solutions Product Portfolio Table 48. BioServUK Recent Development Table 49. GenScript Company Information Table 50. GenScript Business Overview Table 51. GenScript Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. GenScript Laboratory Molecular Cloning Solutions Product Portfolio Table 53. GenScript Recent Development Table 54. urofins Genomics Company Information Table 55. urofins Genomics Business Overview Table 56. urofins Genomics Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. urofins Genomics Laboratory Molecular Cloning Solutions Product Portfolio Table 58. urofins Genomics Recent Development Table 59. Innoprot Company Information Table 60. Innoprot Business Overview Table 61. Innoprot Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Innoprot Laboratory Molecular Cloning Solutions Product Portfolio Table 63. Innoprot Recent Development Table 64. Genewiz Company Information Table 65. Genewiz Business Overview Table 66. Genewiz Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Genewiz Laboratory Molecular Cloning Solutions Product Portfolio Table 68. Genewiz Recent Development Table 69. Bio-Fab Research Company Information Table 70. Bio-Fab Research Business Overview Table 71. Bio-Fab Research Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bio-Fab Research Laboratory Molecular Cloning Solutions Product Portfolio Table 73. Bio-Fab Research Recent Development Table 74. OriGene Company Information Table 75. OriGene Business Overview Table 76. OriGene Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. OriGene Laboratory Molecular Cloning Solutions Product Portfolio Table 78. OriGene Recent Development Table 79. Prospec-Tany Technogene Company Information Table 80. Prospec-Tany Technogene Business Overview Table 81. Prospec-Tany Technogene Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Prospec-Tany Technogene Laboratory Molecular Cloning Solutions Product Portfolio Table 83. Prospec-Tany Technogene Recent Development Table 84. Addgene Company Information Table 85. Addgene Business Overview Table 86. Addgene Laboratory Molecular Cloning Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Addgene Laboratory Molecular Cloning Solutions Product Portfolio Table 88. Addgene Recent Development Table 89. Protein Ark Company Information Table 90. Protein Ark Business Overview Table 91. Protein Ark Laboratory Molecular Cloning Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Protein Ark Laboratory Molecular Cloning Solutions Product Portfolio Table 93. Protein Ark Recent Development Table 94. Protomnis Company Information Table 95. Protomnis Business Overview Table 96. Protomnis Laboratory Molecular Cloning Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Protomnis Laboratory Molecular Cloning Solutions Product Portfolio Table 98. Protomnis Recent Development Table 99. RD-Biotech Company Information Table 100. RD-Biotech Business Overview Table 101. RD-Biotech Laboratory Molecular Cloning Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. RD-Biotech Laboratory Molecular Cloning Solutions Product Portfolio Table 103. RD-Biotech Recent Development Table 104. Charles River Company Information Table 105. Charles River Business Overview Table 106. Charles River Laboratory Molecular Cloning Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Charles River Laboratory Molecular Cloning Solutions Product Portfolio Table 108. Charles River Recent Development Table 109. Shandong Vigene Biosciences Company Information Table 110. Shandong Vigene Biosciences Business Overview Table 111. Shandong Vigene Biosciences Laboratory Molecular Cloning Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Shandong Vigene Biosciences Laboratory Molecular Cloning Solutions Product Portfolio Table 113. Shandong Vigene Biosciences Recent Development Table 114. Nanjingjinsirui Science & Technology Biology Corp. Company Information Table 115. Nanjingjinsirui Science & Technology Biology Corp. Business Overview Table 116. Nanjingjinsirui Science & Technology Biology Corp. Laboratory Molecular Cloning Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Nanjingjinsirui Science & Technology Biology Corp. Laboratory Molecular Cloning Solutions Product Portfolio Table 118. Nanjingjinsirui Science & Technology Biology Corp. Recent Development Table 119. Tiangen Biotech (Beijing) Co., Ltd. Company Information Table 120. Tiangen Biotech (Beijing) Co., Ltd. Business Overview Table 121. Tiangen Biotech (Beijing) Co., Ltd. Laboratory Molecular Cloning Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Tiangen Biotech (Beijing) Co., Ltd. Laboratory Molecular Cloning Solutions Product Portfolio Table 123. Tiangen Biotech (Beijing) Co., Ltd. Recent Development Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Laboratory Molecular Cloning Solutions Product Image Figure 2. Global Laboratory Molecular Cloning Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laboratory Molecular Cloning Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Laboratory Molecular Cloning Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Viral Vector Image Figure 8. Non-viral Vectors Image Figure 9. Global Laboratory Molecular Cloning Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Laboratory Molecular Cloning Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Laboratory Molecular Cloning Solutions Sales Value Share by Type (2021-2032) Figure 12. Laboratory Image Figure 13. Research Institute Image Figure 14. Others Image Figure 15. Global Laboratory Molecular Cloning Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Laboratory Molecular Cloning Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Laboratory Molecular Cloning Solutions Sales Value Share by Application (2021-2032) Figure 18. Global Laboratory Molecular Cloning Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Laboratory Molecular Cloning Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Laboratory Molecular Cloning Solutions Sales Value (2021-2032) & (US$ Million) Figure 21. North America Laboratory Molecular Cloning Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Laboratory Molecular Cloning Solutions Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Laboratory Molecular Cloning Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Laboratory Molecular Cloning Solutions Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Laboratory Molecular Cloning Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Laboratory Molecular Cloning Solutions Sales Value (2021-2032) & (US$ Million) Figure 27. South America Laboratory Molecular Cloning Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Laboratory Molecular Cloning Solutions Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Laboratory Molecular Cloning Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Vector
  • Non-viral Vectors
Applications
  • Laboratory
  • Research Institute
  • Others
Companies covered
  • VectorBuilder
  • BioServUK
  • GenScript
  • urofins Genomics
  • Innoprot
  • Genewiz
  • Bio-Fab Research
  • OriGene
  • Prospec-Tany Technogene
  • Addgene
  • Protein Ark
  • Protomnis
  • RD-Biotech
  • Charles River
  • Shandong Vigene Biosciences
  • Nanjingjinsirui Science & Technology Biology Corp.
  • Tiangen Biotech (Beijing) Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Laboratory Molecular Cloning Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Laboratory Molecular Cloning Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Laboratory Molecular Cloning Solutions Market Dynamics
  1. 2.1 Laboratory Molecular Cloning Solutions Industry Trends
  2. 2.2 Laboratory Molecular Cloning Solutions Industry Drivers
  3. 2.3 Laboratory Molecular Cloning Solutions Industry Opportunities and Challenges
  4. 2.4 Laboratory Molecular Cloning Solutions Industry Restraints
3 Laboratory Molecular Cloning Solutions Market by Company
  1. 3.1 Global Laboratory Molecular Cloning Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Laboratory Molecular Cloning Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Laboratory Molecular Cloning Solutions Company Ranking (2024-2026)
  4. 3.4 Global Laboratory Molecular Cloning Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Laboratory Molecular Cloning Solutions Company Product Type and Application
  6. 3.6 Global Laboratory Molecular Cloning Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Laboratory Molecular Cloning Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Laboratory Molecular Cloning Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Laboratory Molecular Cloning Solutions Market by Type
  1. 4.1 Laboratory Molecular Cloning Solutions Type Introduction
  2. 4.1.1 Viral Vector
  3. 4.1.2 Non-viral Vectors
  4. 4.2 Global Laboratory Molecular Cloning Solutions Sales Value by Type
  5. 4.2.1 Global Laboratory Molecular Cloning Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Laboratory Molecular Cloning Solutions Sales Value by Type (2021-2032)
  7. 4.2.3 Global Laboratory Molecular Cloning Solutions Sales Value Share by Type (2021-2032)
5 Laboratory Molecular Cloning Solutions Market by Application
  1. 5.1 Laboratory Molecular Cloning Solutions Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Laboratory Molecular Cloning Solutions Sales Value by Application
  6. 5.2.1 Global Laboratory Molecular Cloning Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Laboratory Molecular Cloning Solutions Sales Value by Application (2021-2032)
  8. 5.2.3 Global Laboratory Molecular Cloning Solutions Sales Value Share by Application (2021-2032)
6 Laboratory Molecular Cloning Solutions Regional Value Analysis
  1. 6.1 Global Laboratory Molecular Cloning Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Laboratory Molecular Cloning Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Laboratory Molecular Cloning Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Laboratory Molecular Cloning Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Laboratory Molecular Cloning Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Laboratory Molecular Cloning Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Laboratory Molecular Cloning Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Laboratory Molecular Cloning Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Laboratory Molecular Cloning Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Laboratory Molecular Cloning Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Laboratory Molecular Cloning Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Laboratory Molecular Cloning Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Laboratory Molecular Cloning Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Laboratory Molecular Cloning Solutions Sales Value Share by Country, 2025 VS 2032
7 Laboratory Molecular Cloning Solutions Country-level Value Analysis
  1. 7.1 Global Laboratory Molecular Cloning Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Laboratory Molecular Cloning Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Laboratory Molecular Cloning Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Laboratory Molecular Cloning Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Laboratory Molecular Cloning Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Laboratory Molecular Cloning Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Laboratory Molecular Cloning Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 VectorBuilder
  2. 8.1.1 VectorBuilder Company Information
  3. 8.1.2 VectorBuilder Business Overview
  4. 8.1.3 VectorBuilder Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 VectorBuilder Laboratory Molecular Cloning Solutions Product Portfolio
  6. 8.1.5 VectorBuilder Recent Developments
  7. 8.2 BioServUK
  8. 8.2.1 BioServUK Company Information
  9. 8.2.2 BioServUK Business Overview
  10. 8.2.3 BioServUK Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioServUK Laboratory Molecular Cloning Solutions Product Portfolio
  12. 8.2.5 BioServUK Recent Developments
  13. 8.3 GenScript
  14. 8.3.1 GenScript Company Information
  15. 8.3.2 GenScript Business Overview
  16. 8.3.3 GenScript Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GenScript Laboratory Molecular Cloning Solutions Product Portfolio
  18. 8.3.5 GenScript Recent Developments
  19. 8.4 urofins Genomics
  20. 8.4.1 urofins Genomics Company Information
  21. 8.4.2 urofins Genomics Business Overview
  22. 8.4.3 urofins Genomics Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 urofins Genomics Laboratory Molecular Cloning Solutions Product Portfolio
  24. 8.4.5 urofins Genomics Recent Developments
  25. 8.5 Innoprot
  26. 8.5.1 Innoprot Company Information
  27. 8.5.2 Innoprot Business Overview
  28. 8.5.3 Innoprot Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Innoprot Laboratory Molecular Cloning Solutions Product Portfolio
  30. 8.5.5 Innoprot Recent Developments
  31. 8.6 Genewiz
  32. 8.6.1 Genewiz Company Information
  33. 8.6.2 Genewiz Business Overview
  34. 8.6.3 Genewiz Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Genewiz Laboratory Molecular Cloning Solutions Product Portfolio
  36. 8.6.5 Genewiz Recent Developments
  37. 8.7 Bio-Fab Research
  38. 8.7.1 Bio-Fab Research Company Information
  39. 8.7.2 Bio-Fab Research Business Overview
  40. 8.7.3 Bio-Fab Research Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bio-Fab Research Laboratory Molecular Cloning Solutions Product Portfolio
  42. 8.7.5 Bio-Fab Research Recent Developments
  43. 8.8 OriGene
  44. 8.8.1 OriGene Company Information
  45. 8.8.2 OriGene Business Overview
  46. 8.8.3 OriGene Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 OriGene Laboratory Molecular Cloning Solutions Product Portfolio
  48. 8.8.5 OriGene Recent Developments
  49. 8.9 Prospec-Tany Technogene
  50. 8.9.1 Prospec-Tany Technogene Company Information
  51. 8.9.2 Prospec-Tany Technogene Business Overview
  52. 8.9.3 Prospec-Tany Technogene Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Prospec-Tany Technogene Laboratory Molecular Cloning Solutions Product Portfolio
  54. 8.9.5 Prospec-Tany Technogene Recent Developments
  55. 8.10 Addgene
  56. 8.10.1 Addgene Company Information
  57. 8.10.2 Addgene Business Overview
  58. 8.10.3 Addgene Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Addgene Laboratory Molecular Cloning Solutions Product Portfolio
  60. 8.10.5 Addgene Recent Developments
  61. 8.11 Protein Ark
  62. 8.11.1 Protein Ark Company Information
  63. 8.11.2 Protein Ark Business Overview
  64. 8.11.3 Protein Ark Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Protein Ark Laboratory Molecular Cloning Solutions Product Portfolio
  66. 8.11.5 Protein Ark Recent Developments
  67. 8.12 Protomnis
  68. 8.12.1 Protomnis Company Information
  69. 8.12.2 Protomnis Business Overview
  70. 8.12.3 Protomnis Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Protomnis Laboratory Molecular Cloning Solutions Product Portfolio
  72. 8.12.5 Protomnis Recent Developments
  73. 8.13 RD-Biotech
  74. 8.13.1 RD-Biotech Company Information
  75. 8.13.2 RD-Biotech Business Overview
  76. 8.13.3 RD-Biotech Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 RD-Biotech Laboratory Molecular Cloning Solutions Product Portfolio
  78. 8.13.5 RD-Biotech Recent Developments
  79. 8.14 Charles River
  80. 8.14.1 Charles River Company Information
  81. 8.14.2 Charles River Business Overview
  82. 8.14.3 Charles River Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Charles River Laboratory Molecular Cloning Solutions Product Portfolio
  84. 8.14.5 Charles River Recent Developments
  85. 8.15 Shandong Vigene Biosciences
  86. 8.15.1 Shandong Vigene Biosciences Company Information
  87. 8.15.2 Shandong Vigene Biosciences Business Overview
  88. 8.15.3 Shandong Vigene Biosciences Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shandong Vigene Biosciences Laboratory Molecular Cloning Solutions Product Portfolio
  90. 8.15.5 Shandong Vigene Biosciences Recent Developments
  91. 8.16 Nanjingjinsirui Science & Technology Biology Corp.
  92. 8.16.1 Nanjingjinsirui Science & Technology Biology Corp. Company Information
  93. 8.16.2 Nanjingjinsirui Science & Technology Biology Corp. Business Overview
  94. 8.16.3 Nanjingjinsirui Science & Technology Biology Corp. Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Nanjingjinsirui Science & Technology Biology Corp. Laboratory Molecular Cloning Solutions Product Portfolio
  96. 8.16.5 Nanjingjinsirui Science & Technology Biology Corp. Recent Developments
  97. 8.17 Tiangen Biotech (Beijing) Co., Ltd.
  98. 8.17.1 Tiangen Biotech (Beijing) Co., Ltd. Company Information
  99. 8.17.2 Tiangen Biotech (Beijing) Co., Ltd. Business Overview
  100. 8.17.3 Tiangen Biotech (Beijing) Co., Ltd. Laboratory Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tiangen Biotech (Beijing) Co., Ltd. Laboratory Molecular Cloning Solutions Product Portfolio
  102. 8.17.5 Tiangen Biotech (Beijing) Co., Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst